Temporarily enlarged Board of Directors? The temporary ones are experienced in M&A process. Plus new CEO with Roche connection. Due to ongoing layoffs in pharma and biotech expect the layoff to prepare ground for M&A. Obvious candidate to take over is Roche. But there were such rumors in the past and stock peaked at 126 so some bmrn insiders could sell it and make a fortune. Current rumor might be more real. Roche has a trojan horse placed in the company. In any way it looks like a preparation for M&A. Who will be a taker? Some analysts show market price at 80-85, others at around 100. No one is talking 120-130 anymore. Not good for bmrn insiders hoping to make it big, unless they have tons of stock. Portfolio and pipeline look modest. For workforce this is uncertain time. The best have already left. New candidates may come from CMO organizations of dubious quality